Why medical weight loss
Diet and willpower aren't the answer for everyone
For many patients, weight gain isn't a discipline problem — it's a metabolic and hormonal one. GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work by regulating appetite signals, slowing gastric emptying, and improving insulin sensitivity.
The result: patients eat less without feeling deprived, lose weight steadily, and often see improvements in blood sugar, cholesterol, blood pressure, and inflammation along the way.
The result: patients eat less without feeling deprived, lose weight steadily, and often see improvements in blood sugar, cholesterol, blood pressure, and inflammation along the way.
Choose your program
Two clinically proven options
Most Affordable
Semaglutide
The original GLP-1 weight loss therapy
$299 /month
✔
Weekly subcutaneous injection
✔
Average 10–15% body weight loss
✔
Titration from 0.25 mg to 2.4 mg
✔
Monthly clinician check-ins
✔
Quarterly labs included
✔
Compounded by licensed 503A pharmacy
Most Effective
Tirzepatide
Dual GLP-1 / GIP receptor agonist
$449 /month
✔
Weekly subcutaneous injection
✔
Average 15–22% body weight loss
✔
Titration from 2.5 mg to 15 mg
✔
Monthly clinician check-ins
✔
Quarterly labs included
✔
Compounded by licensed 503A pharmacy
Eligibility
Is this program right for you?
You're likely a good candidate if:
✔
BMI ≥ 30, or BMI ≥ 27 with a weight-related conditio
✔
Type 2 diabetes or prediabetes
✔
High blood pressure or cholesterol
✔
Sleep apnea or fatty liver disease
✔
You've struggled to lose weight with diet alone
This program is not appropriate if you have:
✗
Personal or family history of medullary thyroid carcinoma
✗
Multiple Endocrine Neoplasia syndrome type 2
✗
History of pancreatitis
✗
Active pregnancy or breastfeeding
✗
A current eating disorder
How it works
From consultation to results
1
Consultation
30-minute visit to review your health history, weight goals, and medications.
2
Baseline labs
Metabolic panel, A1C, lipids, and thyroid screening to confirm eligibility.
3
Start treatment
Medication shipped to your door. We teach you how to self-inject at your first visit.
4
Monthly follow-ups
Weight, side effects, and dose titration reviewed at every visit.
What you can expect
Steady, sustainable loss
Most patients lose 1–2 lbs per week after the titration phase. No crash diets, no starvation.
Reduced appetite & cravings
"Food noise" quiets within the first few weeks. Patients describe it as freedom, not deprivation.
Manageable side effects
Nausea, constipation, and fatigue are common early on but usually resolve with proper titration.
Metabolic improvements
Blood sugar, lipids, and blood pressure often improve alongside weight loss.
COMMON QUESTIONS
Frequently Asked Questions
Will my insurance cover this?
Some commercial plans cover brand-name Wegovy or Zepbound for qualifying patients. Compounded versions are typically self-pay. We'll review your benefits during consultation.
How long do I stay on the medication?
GLP-1s are intended as long-term therapy for chronic weight management. Discontinuation often leads to weight regain. We'll discuss maintenance dosing once you reach your goal.
What about muscle loss?
Rapid weight loss can cost lean mass. We pair every program with protein guidance, resistance training recommendations, and optional peptide therapy to preserve muscle.
Why your clinic instead of an online provider?
In-person assessment, real labs, real follow-ups, and a clinician you can actually reach. Telehealth weight loss has its place — but for most patients, supervised care produces better outcomes and safer titration.
Looking for medical weight loss?
Many of our weight loss patients also benefit from peptide therapy for recovery, energy, and body composition during their journey.
Many of our weight loss patients also benefit from peptide therapy for recovery, energy, and body composition during their journey.
Take the first step
Schedule a consultation to find out if our medical weight loss program is right for you.
Semaglutide and tirzepatide are FDA-approved medications. Compounded versions are prepared by licensed 503A pharmacies for individual patients and are not FDA-approved as compounded products. Individual results vary. Side effects, contraindications, and warnings will be discussed at your consultation. This page is informational and not a substitute for medical advice.
